News
-
-
-
-
-
-
PRESS RELEASE
FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication
FSD Pharma partners with ASPI to conduct a study on unbuzzd™, a supplement for alcohol intoxication. The study aims to assess safety and efficacy in healthy volunteers -
PRESS RELEASE
Tharimmune To Participate in Two Upcoming Investor Conferences in May
Tharimmune to present at investor conferences in May 2024, showcasing developments in inflammation & immunology therapies. CEO to participate in Planet MicroCap Showcase: VEGAS 2024 & EF Hutton Annual Global Conference -
-
-